Global Biologics Contract Development and Manufacturing Organization (CDMO) Market 2025-2029
생물제제 개발 제조 수탁 기관(CDMO) 시장, 2025-2029년
생물제제 개발 제조 수탁 기관(CDMO) 시장은 2024-2029년에 163억 2,460만 달러, 예측 기간 중 CAGR은 13.7%로 성장할 것으로 예측됩니다. 생물제제 개발 제조 수탁 기관(CDMO) 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 신흥 국가 시장에서 비용 효율적인 자원의 가용성, 생물제제 치료제의 강력한 R&D 파이프라인, 핵심 역량에 집중할 필요성 증가 등이 시장을 주도하고 있습니다.
| 시장 범위 |
| 기준연도 |
2025년 |
| 종료연도 |
2029년 |
| 예측 기간 |
2025-2029년 |
| 성장 모멘텀 |
가속 |
| 전년 대비(2025년) 대비 |
11% |
| CAGR |
13.7% |
| 증분액 |
163억 2,460만 달러 |
이 보고서는 빅데이터의 출현이 향후 수년간 CDMO 시장 성장을 촉진할 주요 요인 중 하나로 꼽고 있습니다. 또한 CDMO 벤더와 제약사 간의 전략적 제휴 및 파트너십, 신규 분자 및 바이오시밀러의 승인 증가도 시장의 큰 수요로 이어질 것으로 예상됩니다.
목차
제1장 개요
제2장 Technavio 분석
- 가격·수명주기·고객 구입 바스켓·채택률·구입 기준의 분석
- 인풋의 중요성과 차별화의 요인
- 혼란의 요인
- 촉진요인과 과제의 영향
제3장 시장 구도
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모 2024년
- 시장 전망 2024-2029년
제5장 시장 규모 실적
- 세계의 생물제제 개발 제조 수탁 기관(CDMO) 시장 2019-2023년
- 유형별 부문 분석 2019-2023년
- 제품 유형별 부문 분석 2019-2023년
- 지역별 부문 분석 2019-2023년
- 국가별 부문 분석 2019-2023년
제6장 정성 분석
- AI의 영향 : 세계의 생물제제 개발 제조 수탁 기관(CDMO) 시장
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 현황
제8장 시장 세분화 : 유형별
- 시장 부문
- 비교 : 유형별
- 포유류 : 시장 규모와 예측 2024-2029년
- 미생물 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 유형별
제9장 시장 세분화 : 제품 유형별
- 시장 부문
- 비교 : 제품 유형별
- 생물제제 : 시장 규모와 예측 2024-2029년
- 바이오시밀러 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 제품 유형별
제10장 고객 상황
제11장 지역별 상황
- 지역별 세분화
- 비교 : 지역별
- 북미 : 시장 규모와 예측 2024-2029년
- 유럽 : 시장 규모와 예측 2024-2029년
- 아시아 : 시장 규모와 예측 2024-2029년
- 기타 : 시장 규모와 예측 2024-2029년
- 미국 : 시장 규모와 예측 2024-2029년
- 독일 : 시장 규모와 예측 2024-2029년
- 캐나다 : 시장 규모와 예측 2024-2029년
- 프랑스 : 시장 규모와 예측 2024-2029년
- 중국 : 시장 규모와 예측 2024-2029년
- 영국 : 시장 규모와 예측 2024-2029년
- 일본 : 시장 규모와 예측 2024-2029년
- 이탈리아 : 시장 규모와 예측 2024-2029년
- 인도 : 시장 규모와 예측 2024-2029년
- 한국 : 시장 규모와 예측 2024-2029년
- 지역 상황에 의한 시장 기회
제12장 촉진요인·과제·기회·억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 촉진요인과 과제의 영향
- 시장 기회·억제요인
제13장 경쟁 구도
제14장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- AbbVie Inc.
- Binex Co. Ltd.
- Boehringer Ingelheim International GmbH
- Bora Pharmaceuticals
- Catalent Inc.
- Evonik Industries AG
- FUJIFILM Corp.
- Grifols SA
- J RETTENMAIER and SOHNE GmbH and Co KG
- Lonza Group Ltd.
- Novartis AG
- Rentschler Biopharma SE
- Samsung Electronics Co. Ltd.
- Toyobo Co. Ltd.
- WuXi Biologics Cayman Inc.
제15장 부록
KSA
Biologics Contract Development And Manufacturing Organization (CDMO) Market 2025-2029
The biologics contract development and manufacturing organization (CDMO) market is forecasted to grow by USD 16324.6 mn during 2024-2029, accelerating at a CAGR of 13.7% during the forecast period. The report on the biologics contract development and manufacturing organization (CDMO) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of cost-efficient resources in emerging markets, strong research and development pipeline of biologics therapeutics, and growing need to focus on core competencies.
| Market Scope |
|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 11% |
| CAGR | 13.7% |
| Incremental Value | $16324.6 mn |
Technavio's biologics contract development and manufacturing organization (CDMO) market is segmented as below:
By Type
By Product Type
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the advent of big data as one of the prime reasons driving the biologics contract development and manufacturing organization (CDMO) market growth during the next few years. Also, strategic alliances and partnerships of cdmo vendors with pharma companies and increasing approvals for new molecules and biosimilars will lead to sizable demand in the market.
The report on the biologics contract development and manufacturing organization (CDMO) market covers the following areas:
- Biologics Contract Development And Manufacturing Organization (CDMO) Market sizing
- Biologics Contract Development And Manufacturing Organization (CDMO) Market forecast
- Biologics Contract Development And Manufacturing Organization (CDMO) Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologics contract development and manufacturing organization (CDMO) market vendors that include 3P Biopharmaceuticals, AbbVie Inc., AGC Biologics, Binex Co. Ltd., Boehringer Ingelheim International GmbH, Bora Pharmaceuticals, Catalent Inc., Evonik Industries AG, FUJIFILM Corp., Grifols SA, J RETTENMAIER and SOHNE GmbH and Co KG, JSR Corp., Kemwell Biopharma Pvt. Ltd., Lonza Group Ltd., Novartis AG, Rentschler Biopharma SE, Samsung Electronics Co. Ltd., Shenzhen Hepalink Pharmaceutical Co. Ltd., Toyobo Co. Ltd., and WuXi Biologics Cayman Inc.. Also, the biologics contract development and manufacturing organization (CDMO) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Biologics Contract Development And Manufacturing Organization (CDMO) Market 2019 - 2023
- Historic Market Size - Data Table on Global Biologics Contract Development And Manufacturing Organization (CDMO) Market 2019 - 2023 ($ million)
- 5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- 5.3 Product Type segment analysis 2019 - 2023
- Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
- 5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on the Global Biologics Contract Development and Manufacturing Organization (CDMO) Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
- 8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 8.3 Mammalian - Market size and forecast 2024-2029
- Chart on Mammalian - Market size and forecast 2024-2029 ($ million)
- Data Table on Mammalian - Market size and forecast 2024-2029 ($ million)
- Chart on Mammalian - Year-over-year growth 2024-2029 (%)
- Data Table on Mammalian - Year-over-year growth 2024-2029 (%)
- 8.4 Microbial - Market size and forecast 2024-2029
- Chart on Microbial - Market size and forecast 2024-2029 ($ million)
- Data Table on Microbial - Market size and forecast 2024-2029 ($ million)
- Chart on Microbial - Year-over-year growth 2024-2029 (%)
- Data Table on Microbial - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Product Type
- 9.1 Market segments
- Chart on Product Type - Market share 2024-2029 (%)
- Data Table on Product Type - Market share 2024-2029 (%)
- 9.2 Comparison by Product Type
- Chart on Comparison by Product Type
- Data Table on Comparison by Product Type
- 9.3 Biologics - Market size and forecast 2024-2029
- Chart on Biologics - Market size and forecast 2024-2029 ($ million)
- Data Table on Biologics - Market size and forecast 2024-2029 ($ million)
- Chart on Biologics - Year-over-year growth 2024-2029 (%)
- Data Table on Biologics - Year-over-year growth 2024-2029 (%)
- 9.4 Biosimilars - Market size and forecast 2024-2029
- Chart on Biosimilars - Market size and forecast 2024-2029 ($ million)
- Data Table on Biosimilars - Market size and forecast 2024-2029 ($ million)
- Chart on Biosimilars - Year-over-year growth 2024-2029 (%)
- Data Table on Biosimilars - Year-over-year growth 2024-2029 (%)
- 9.5 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
- Data Table on Market opportunity by Product Type ($ million)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 11.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 11.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 11.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 11.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 11.9 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 11.10 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 11.11 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 11.12 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 11.13 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 11.14 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 11.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 11.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
- 12.1 Market drivers
- 12.2 Market challenges
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 12.4 Market opportunities/restraints
13 Competitive Landscape
- 13.1 Overview
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14.1 Companies profiled
- 14.2 Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
- 14.5 Binex Co. Ltd.
- Binex Co. Ltd. - Overview
- Binex Co. Ltd. - Product / Service
- Binex Co. Ltd. - Key offerings
- SWOT
- 14.6 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
- 14.7 Bora Pharmaceuticals
- Bora Pharmaceuticals - Overview
- Bora Pharmaceuticals - Product / Service
- Bora Pharmaceuticals - Key offerings
- SWOT
- 14.8 Catalent Inc.
- Catalent Inc. - Overview
- Catalent Inc. - Business segments
- Catalent Inc. - Key offerings
- Catalent Inc. - Segment focus
- SWOT
- 14.9 Evonik Industries AG
- Evonik Industries AG - Overview
- Evonik Industries AG - Business segments
- Evonik Industries AG - Key news
- Evonik Industries AG - Key offerings
- Evonik Industries AG - Segment focus
- SWOT
- 14.10 FUJIFILM Corp.
- FUJIFILM Corp. - Overview
- FUJIFILM Corp. - Business segments
- FUJIFILM Corp. - Key news
- FUJIFILM Corp. - Key offerings
- FUJIFILM Corp. - Segment focus
- SWOT
- 14.11 Grifols SA
- Grifols SA - Overview
- Grifols SA - Business segments
- Grifols SA - Key news
- Grifols SA - Key offerings
- Grifols SA - Segment focus
- SWOT
- 14.12 J RETTENMAIER and SOHNE GmbH and Co KG
- J RETTENMAIER and SOHNE GmbH and Co KG - Overview
- J RETTENMAIER and SOHNE GmbH and Co KG - Product / Service
- J RETTENMAIER and SOHNE GmbH and Co KG - Key offerings
- SWOT
- 14.13 Lonza Group Ltd.
- Lonza Group Ltd. - Overview
- Lonza Group Ltd. - Business segments
- Lonza Group Ltd. - Key news
- Lonza Group Ltd. - Key offerings
- Lonza Group Ltd. - Segment focus
- SWOT
- 14.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 14.15 Rentschler Biopharma SE
- Rentschler Biopharma SE - Overview
- Rentschler Biopharma SE - Product / Service
- Rentschler Biopharma SE - Key offerings
- SWOT
- 14.16 Samsung Electronics Co. Ltd.
- Samsung Electronics Co. Ltd. - Overview
- Samsung Electronics Co. Ltd. - Business segments
- Samsung Electronics Co. Ltd. - Key news
- Samsung Electronics Co. Ltd. - Key offerings
- Samsung Electronics Co. Ltd. - Segment focus
- SWOT
- 14.17 Toyobo Co. Ltd.
- Toyobo Co. Ltd. - Overview
- Toyobo Co. Ltd. - Business segments
- Toyobo Co. Ltd. - Key news
- Toyobo Co. Ltd. - Key offerings
- Toyobo Co. Ltd. - Segment focus
- SWOT
- 14.18 WuXi Biologics Cayman Inc.
- WuXi Biologics Cayman Inc. - Overview
- WuXi Biologics Cayman Inc. - Product / Service
- WuXi Biologics Cayman Inc. - Key offerings
- SWOT
15 Appendix
- 15.1 Scope of the report
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.5 Data procurement
- 15.6 Data validation
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.8 Data synthesis
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
